STEAD WILLIAM - 29 May 2025 Form 4 Insider Report for HEALTHSTREAM INC (HSTM)

Role: Director
Signature: /s/ William W. Stead
Issuer symbol: HSTM
Transactions as of: 29 May 2025
Transactions value $: $0
Form type: 4
Filing time: 30 May 2025, 16:24:51 UTC
Previous filing: 28 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
STEAD WILLIAM	Director	500 11TH AVENUE NORTH, SUITE 850, NASHVILLE	/s/ William W. Stead	30 May 2025	0001217355

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HSTM	Common Stock Holding	Award	$0	+5.27K	+12.25%	$0.00	48.3K	29 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HSTM	Restricted Share Units	Options Exercise	$0	+2.25K		$0.00	0	29 May 2025	Common Stock	2.25K	$0.00	Direct	F2, F3, F4
transaction	HSTM	Restricted Share Units	Options Exercise	$0	+3.02K		$0.00	0	29 May 2025	Common Stock	3.02K	$0.00	Direct	F2, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares acquired upon acceleration of the vesting of multiple grants of restricted share units ("RSUs") upon Dr. Stead's retirement from service on the Board of Directors ("Board") of HealthStream, Inc. (the "Company").
F2	Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
F3	Reflects an amendment made to the terms of previously granted RSUs to provide for acceleration of the vesting of the unvested RSUs in connection with Dr. Stead's retirement from service on the Company's Board. These RSUs were initially subject to a three-year vesting schedule, contingent upon continued service at the time of vesting, and were originally scheduled to vest annually beginning June 6, 2024 in three equal installments. In connection with Dr. Stead's decision to retire from service on the Board effective concurrently with the Company's 2025 annual meeting of shareholders, the Company's Compensation Committee approved the accelerated vesting of all unvested RSUs to instead vest concurrent with his retirement as of the annual shareholder meeting date of May 29, 2025.
F4	Not applicable.
F5	Reflects an amendment made to the terms of previously granted RSUs to provide for acceleration of the vesting of the unvested RSUs in connection with Dr. Stead's retirement from service on the Company's Board. These RSUs were initially subject to a three-year vesting schedule, contingent upon continued service at the time of vesting, and were originally scheduled to vest annually beginning May 30, 2025 in three equal installments. In connection with Dr. Stead's decision to retire from service on the Board effective concurrently with the Company's 2025 annual meeting of shareholders, the Company's Compensation Committee approved the accelerated vesting of all unvested RSUs to instead vest concurrent with his retirement as of the annual shareholder meeting date of May 29, 2025.